Abbott launches MRD test with improved cancer detection tech

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 27 Oct, 14:14 UTC

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of the Oncodetect test performs and the market it addresses.

science

Sources

• T2Abbott launches MRD test with improved cancer detection techBioPharma Dive / Healthcare Dive / MedTech Dive27 Oct, 14:14